about
Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replicationHigh incidence of Epstein-Barr virus, cytomegalovirus and human herpesvirus 6 infections in children with cancerRole of human cytomegalovirus tegument proteins in virion assemblyAn artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activitiesEfficacy and Mechanism of Action of Low Dose Emetine against Human CytomegalovirusAssociation of cytomegalovirus infection with hypertension risk: a meta-analysis.Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine.Central nervous system infection during immunosuppression.Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers.The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation.Antifungal and antiviral chemotherapy.HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytesArtemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent PathwayWnt modulating agents inhibit human cytomegalovirus replication.Prevalence of human herpesvirus 6 antibodies and DNA in allogeneic stem cell transplant patients: two-year single centre experience.Manipulation of dendritic cell functions by human cytomegalovirus.Comparison of two methods used for monitoring low-copy cytomegalovirus infection in a patient with chronic myeloid leukemia after unrelated umbilical cord blood transplantation.Co-infections with cytomegalovirus and human herpesvirus type 7 in adult Polish allogeneic haematopoietic stem cell transplant recipients.In vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action.Xenotransplantation and porcine cytomegalovirus.Efficacy of Antimicrobial Therapy for Mycoplasma genitalium Infections.Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA.Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents.Quantification of Active and Latent Form of Human Cytomegalovirus Infection in Umbilical Cord Blood Donors by Real-Time PCRQuantitative polymerase chain reaction for detection of human herpesvirus-7 infection in umbilical cord blood donors.Simultaneous monitoring of CMV and human herpesvirus 6 infections and diseases in liver transplant patients: one-year follow-up.Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection.Digitoxin suppresses human cytomegalovirus replication via Na+, K+/ATPase α1 subunit-dependent AMPK and autophagy activation.Human Herpesvirus 6
P2860
Q24293059-5F283989-EDD0-4753-907D-96FE5B67578BQ24800206-EB9C374E-4D47-4159-8897-CD7CB2E20DD3Q27015069-B2C14353-0369-476C-A9B3-60198D10531EQ28476748-DBE67A2A-11A8-4A8F-9FD4-2B9F170E01CDQ28552095-11E3A97C-C764-4D28-A93D-6981A3B24953Q30251777-41283FC4-8136-44E6-9853-8F56F38E9DD2Q33815957-E5B020C1-2165-4900-84E3-D14642EBAD5EQ34194312-3B82D14E-9E04-4331-B968-71A79E13C983Q34469041-4388EF81-4A37-4651-9D2E-4A4CC73E39ABQ34619259-A01F7F15-29B1-4415-A059-655A9D814A02Q34619691-54071B69-3B4F-4791-AAAF-421B942B1DF3Q34639628-877B7472-882E-41C6-BB65-6C3E15DDE9D5Q35978622-6FB4A02D-D08C-40D5-92D6-D4E78AF0987CQ36086432-D23E992A-45C6-47CE-BC55-C0282DC98DC7Q36172394-B082C34D-3CBC-4087-8E9D-FEF08A136B16Q36528505-5975D33D-871A-48DD-A8A4-E6754DC40CFBQ37026623-15D85BB7-3C0E-4B0A-9E2B-8AE527798A66Q37177116-CBBCC669-7B0E-4218-8866-6BC8893BBEA6Q37331842-02F0EEC1-7F96-45A3-B175-6ED5B78451C5Q37395988-3C95EC05-2DDC-474E-ACF1-73E13CBE55F8Q37501878-5725F9D3-E2B8-4026-82A5-D5E8F6C4F876Q37544751-A9707155-5827-4853-B0D5-65B0B6254DBAQ38588603-F6DFC358-4601-4F1C-8641-76467514A4F8Q38646438-0467ACFB-5F9F-45DF-9A66-A62FB3ACAC7EQ39627926-44ED073D-B349-43EA-BA4A-62315B241F6BQ40233323-5E3C910F-FCCD-4D86-AC02-65925F7E872BQ41444225-DDE07785-1486-4E05-B75B-38051B1A132DQ41640169-FEB0B568-9BEC-421D-95DF-74148E0FF790Q42787459-F310E797-DD11-411B-ABB4-C1C4B34E26AEQ44412730-3E82EFEB-3214-4574-BDFF-3E947BF22CEEQ47555910-EA5AEA73-2206-4BB5-974D-591D974EDE9BQ58661813-8DA8ADCE-81D0-4146-829F-5B4F9163E918
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Betaherpesviruses in transplant recipients.
@ast
Betaherpesviruses in transplant recipients.
@en
type
label
Betaherpesviruses in transplant recipients.
@ast
Betaherpesviruses in transplant recipients.
@en
prefLabel
Betaherpesviruses in transplant recipients.
@ast
Betaherpesviruses in transplant recipients.
@en
P2093
P356
P1476
Betaherpesviruses in transplant recipients.
@en
P2093
P356
10.1093/JAC/45.SUPPL_4.29
P407
P478
45 Suppl T3
P577
2000-04-01T00:00:00Z